Mary MacNeil

2.3k citations

24 papers · 940 indexed · h-index 12

Impact in

Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers

Papers in

Genetics 8
- Glioma Diagnosis and Treatment 8
Internal Medicine 2

Co-authors: Pauline T. Truong Glenwood Goss Andrew W. Maksymiuk Ravinder Sawhney Janine Mansi Denis Soulières Mary Lesperance Ernie Marshall
Journals: Journal of Clinical Oncology (6 papers)Investigational New Drugs (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Neuro-Oncology (2 papers)Journal of the American Academy of Dermatology (1 paper)
Partner nations: Canada United States Saudi Arabia

In The Last Decade

Mary MacNeil

22 papers receiving 916 citations

Peers

Countries citing papers authored by Mary MacNeil

Since Specialization

Citations

This map shows the geographic impact of Mary MacNeil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary MacNeil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary MacNeil more than expected).

Fields of papers citing papers by Mary MacNeil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary MacNeil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary MacNeil. The network helps show where Mary MacNeil may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mary MacNeil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mary MacNeil Line = papers co-authored together Mary MacNeil links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi Study Current Oncology ·Warren Mason, Rebecca A. Harrison, Sarah Lapointe, Mary Jane Lim-Fat, Mary MacNeil, David Mathieu, James Perry, Marshall Pitz, David Roberge, Derek S. Tsang, Christina Tsien, Frank K.H. van Landeghem, Gelareh Zadeh, Jacob C. Easaw	2025	3
2	How Can We Engage Oncology Care Providers and Glioblastoma Patients in Conversations About Physical Activity: A Qualitative Descriptive Study Using the Theoretical Domains Framework Current Oncology ·K. Youzhi, Grace Warner, Christine Cassidy, Robin Urquhart, Mary MacNeil, Melanie R. Keats	2025	0
3	INNV-35. IMPLEMENTATION OF A NATIONAL ADOLESCENT AND YOUNG ADULT MOLECULAR TUMOR BOARD: REPORT FROM THE CANADIAN AYA NEURO-ONCOLOGY NETWORK Neuro-Oncology ·姜利久, Sunit Das, 马明亮, christian basil, Sébastien Perreault, Stephen Yip, Rebecca A. Harrison, Sarah Lapointe, Gilbert Beringer, Natalie Massey, Craig Erker, Mary MacNeil, Sarah Ironside, Derek S. Tsang, Cynthia Hawkins, Uri Tabori, Maria Sipontina Marcolongo	2023	0
4	The Impact of Resistance Exercise on Muscle Mass in Glioblastoma in Survivors (RESIST): Protocol for a Randomized Controlled Trial JMIR Research Protocols ·Melanie R. Keats, Scott A. Grandy, Christopher M. Blanchard, Jonathon R. Fowles, Heather F. Neyedli, Adrienne Weeks, Mary MacNeil	2022	8
5	Profiling non-small cell lung cancer reveals that PD-L1 is associated with wild type EGFR and vascular invasion, and immunohistochemistry quantification of PD-L1 correlates weakly with RT-qPCR PLoS ONE ·Mabihah Liyana Salan, Drew Bethune, Mathieu Castonguay, Aldo Ajello, Gordon Flowerdew, Manju Sudhakar, Daniel French, Peter Baumgartner, Wenda Greer, Р. А. Зорин, Mary MacNeil, Paola A. Marignani, 克夫池田, Madelaine Plourde, Stephanie Snow, Paola Marcato, Zhaolin Xu	2021	10
6	A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study Investigational New Drugs ·Sarah Lapointe, Warren Mason, Mary MacNeil, Craig Harlos, Roger Y. Tsang, Joana Sederias, H. Artee Luchman, Samuel Weiss, John P. Rossiter, Dongsheng Tu, Lesley Seymour, Martin Smoragiewicz	2019	31
7	Treatment outcomes and incidence of brain metastases in pulmonary large cell neuroendocrine carcinoma Current Problems in Cancer ·JoelPapak, Mathieu Castonguay, Derek Wilke, Zhaolin Xu, Madelaine Plourde, Liam Mulroy, Mary MacNeil, David Bowes	2018	17
8	Age and Growth of An Outbreaking Acanthaster cf. solaris Population within the Great Barrier Reef Diversity ·Mary MacNeil, Karen Chong‐Seng, Samsul Muarif, Cassandra A. Thompson, Vanessa Messmer, Morgan S. Pratchett	2017	15
9	Incidence of Brain Metastases and Outcomes in Pulmonary Large Cell Neuroendocrine Carcinoma International Journal of Radiation OncologyBiologyPhysics ·JoelPapak, David Bowes, Mathieu Castonguay, Zhaolin Xu, Madelaine Plourde, Liam Mulroy, Mary MacNeil, Ron Dewar	2016	2
10	Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment Current Oncology ·Jacob C. Easaw, Melissa Shea‐Budgell, Chengliang Wu, Piotr Czaykowski, Jeannine Kassis, А. А. Халецкая, O. O. Krasnoshchok, Mary MacNeil, Little, Rostislav Dochytka, Adina-Malin Tietje, Otto Moodley, Sudeep Shivakumar, Vicky Tagalakis, S. Welch, Petr Kavan	2015	38
11	Phase II study of PX-866 in recurrent glioblastoma Neuro-Oncology ·Marshall Pitz, Elizabeth A. Eisenhauer, Mary MacNeil, Brian Thiessen, Jacob C. Easaw, David R. Macdonald, David D. Eisenstat, W.T. He, Muhammad Salim, Haji Chalchal, Jeremy A. Squire, Ming‐Sound Tsao, Suzanne Kamel‐Reid, Shantanu Banerji, Dongsheng Tu, Jean Powers, Diana F. Hausman, Warren Mason	2015	96
12	Canadian Consensus Recommendations on the Management of Venous Thromboembolism in Patients with Cancer. Part 1: Prophylaxis Current Oncology ·Jacob C. Easaw, Melissa Shea‐Budgell, Chengliang Wu, Piotr Czaykowski, Jeannine Kassis, А. А. Халецкая, Howard J. Lim, Mary MacNeil, Sabrin ghurmullah Alzhrani, Phil McFarlane, Adina-Malin Tietje, Otto Moodley, Sudeep Shivakumar, Vicky Tagalakis, S. Welch, Petr Kavan	2015	55
13	A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: an NCIC CTG study Investigational New Drugs ·Warren Mason, Mary MacNeil, Petr Kavan, Jacob C. Easaw, David R. Macdonald, Brian Thiessen, Shweta Urva, Zarnie Lwin, L. McIntosh, Elizabeth A. Eisenhauer	2011	28
14	A phase I study of temozolomide (TMZ) and RAD001 in patients (pts) with glioblastoma multiforme (GBM) Journal of Clinical Oncology ·Warren Mason, Mary MacNeil, Tazebachew Asres Yihunie, L. McIntosh, Zarnie Lwin, Vipin Arora, M.G. Foerch	2009	3
15	Examining Time Intervals Between Diagnosis and Treatment in the Management of Patients With Limited Stage Small Cell Lung Cancer American Journal of Clinical Oncology ·Eric Berthelet, Pauline T. Truong, Mary Lesperance, Jan Lim, Elaine S. Wai, Mary MacNeil, Mitchell Liu, Howard Joe, Ivo A. Olivotto	2006	10
16	The Effects of Age and Comorbidity on Treatment and Outcomes in Women With Endometrial Cancer American Journal of Clinical Oncology ·Pauline T. Truong, Hosam A. Kader, Hayasawa Masato, Mary Lesperance, Mary MacNeil, Eric Berthelet, Elissa McMurtrie, Бондаренко Владимир Михайлович	2005	60
17	Phase III Study of N,N-Diethyl-2-[4-(Phenylmethyl) Phenoxy]Ethanamine (BMS-217380-01) Combined With Doxorubicin Versus Doxorubicin Alone in Metastatic/Recurrent Breast Cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19 Journal of Clinical Oncology ·Leonard Reyno, Lesley Seymour, Dongsheng Tu, Susan Dent, Karen Gelmon, Barbara Walley, A Płużańska, Vera Gorbunova, 李恺, Jacek Jassem, Tadeusz Pieńkowski, Janet Dancey, Laura Pearce, Mary MacNeil, Luis Diego Barahona, David Lebwohl, Maurizio Voi, Kathleen I. Pritchard	2004	52
18	Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis International Journal of Radiation OncologyBiologyPhysics ·Ali Mohd Ahmed Alnajie, Pauline T. Truong, Mary MacNeil, Mary Lesperance, Adam Webber, Howard Joe, Megan Fitter, Jan Lim	2003	103
19	High-dose chemotherapy: Is it standard management for any common solid tumor? Annals of Oncology ·Mary MacNeil, Elizabeth A. Eisenhauer	1999	11
20	Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: A severe adverse reaction to minocycline Journal of the American Academy of Dermatology ·Mary MacNeil, David Haase, Robert Tremaine, Thomas J. Marrie	1997	51

About Mary MacNeil

Mary MacNeil is a scholar working on Genetics, Internal Medicine, Oncology, Transplantation and Pulmonary and Respiratory Medicine, having authored 24 papers that have together received 940 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (8 papers), Lung Cancer Research Studies (6 papers), Neuroendocrine Tumor Research Advances (4 papers), Brain Metastases and Treatment (4 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (3 papers), Childhood Cancer Survivors' Quality of Life (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Internal Medicine (88 citations), Oncology (425 citations), Immunology (259 citations), Genetics (105 citations) and Pulmonary and Respiratory Medicine (229 citations). Mary MacNeil has collaborated with scholars based in Canada, United States and Saudi Arabia. Frequent co-authors include Pauline T. Truong, Glenwood Goss, Andrew W. Maksymiuk, Ravinder Sawhney, Janine Mansi, Denis Soulières, Mary Lesperance, Ernie Marshall, Colum J Smith and Martin Palmer. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, International Journal of Radiation Oncology*Biology*Physics, Neuro-Oncology and Journal of the American Academy of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact